| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13573* | 2021 |
| Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards V Bronte, S Brandau, SH Chen, MP Colombo, AB Frey, TF Greten, ... Nature communications 7 (1), 12150, 2016 | 2657 | 2016 |
| The terminology issue for myeloid-derived suppressor cells DI Gabrilovich, V Bronte, SH Chen, MP Colombo, A Ochoa, ... Cancer research 67 (1), 425-425, 2007 | 1022 | 2007 |
| Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells G Gallina, L Dolcetti, P Serafini, C De Santo, I Marigo, MP Colombo, ... The Journal of clinical investigation 116 (10), 2777-2790, 2006 | 995 | 2006 |
| Interleukin-12 in anti-tumor immunity and immunotherapy MP Colombo, G Trinchieri Cytokine & growth factor reviews 13 (2), 155-168, 2002 | 940 | 2002 |
| Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. P Paglia, C Chiodoni, M Rodolfo, MP Colombo The Journal of experimental medicine 183 (1), 317-322, 1996 | 776 | 1996 |
| Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection C Guiducci, AP Vicari, S Sangaletti, G Trinchieri, MP Colombo Cancer research 65 (8), 3437-3446, 2005 | 705 | 2005 |
| Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry SG Priori, M Gasparini, C Napolitano, P Della Bella, AG Ottonelli, ... Journal of the American College of Cardiology 59 (1), 37-45, 2012 | 703 | 2012 |
| IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice V Bronte, P Serafini, C De Santo, I Marigo, V Tosello, A Mazzoni, ... The Journal of Immunology 170 (1), 270-278, 2003 | 659 | 2003 |
| p50 nuclear factor-κB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance A Saccani, T Schioppa, C Porta, SK Biswas, M Nebuloni, L Vago, ... Cancer research 66 (23), 11432-11440, 2006 | 592 | 2006 |
| Classification of current anticancer immunotherapies L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ... Oncotarget 5 (24), 12472, 2014 | 585 | 2014 |
| The intriguing role of polymorphonuclear neutrophils in antitumor reactions E Di Carlo, G Forni, PL Lollini, MP Colombo, A Modesti, P Musiani Blood, The Journal of the American Society of Hematology 97 (2), 339-345, 2001 | 572 | 2001 |
| Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy MP Colombo, S Piconese Nature Reviews Cancer 7 (11), 880-887, 2007 | 535 | 2007 |
| CD4+ CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction G Gri, S Piconese, B Frossi, V Manfroi, S Merluzzi, C Tripodo, A Viola, ... Immunity 29 (5), 771-781, 2008 | 494 | 2008 |
| Triggering of OX40 (CD134) on CD4+ CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR B Valzasina, C Guiducci, H Dislich, N Killeen, AD Weinberg, MP Colombo Blood 105 (7), 2845-2851, 2005 | 484 | 2005 |
| Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25− into CD25+ T regulatory cells A Curti, S Pandolfi, B Valzasina, M Aluigi, A Isidori, E Ferri, V Salvestrini, ... Blood 109 (7), 2871-2877, 2007 | 469 | 2007 |
| Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake S Todryk, AA Melcher, N Hardwick, E Linardakis, A Bateman, ... The Journal of Immunology 163 (3), 1398-1408, 1999 | 466 | 1999 |
| Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti–interleukin 10 receptor antibody AP Vicari, C Chiodoni, C Vaure, S Aït-Yahia, C Dercamp, F Matsos, ... The Journal of experimental medicine 196 (4), 541-549, 2002 | 464 | 2002 |
| The promyelocytic leukemia zinc finger–microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms F Felicetti, MC Errico, L Bottero, P Segnalini, A Stoppacciaro, M Biffoni, ... Cancer research 68 (8), 2745-2754, 2008 | 463 | 2008 |
| OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection S Piconese, B Valzasina, MP Colombo The Journal of experimental medicine 205 (4), 825-839, 2008 | 463 | 2008 |
